<html>
<head>PUBMED IDs for TAFII30</head>
<body bgcolor='#C5F0F2'><h1>TAFII30</h1><a href='https://pubmed.ncbi.nlm.nih.gov/7923369/'>Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor.</a> October 7  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/7923368/'>Has the breast cancer gene been found?</a> October 7  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/7729427/'>Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID.</a> April 3  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/8530084/'>Organization and chromosomal localization of the gene (TAF2H) encoding the human TBP-associated factor II 30 (TAFII30).</a> September 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/9653647/'>Structural organization and sequence of CLN2, the defective gene in classical late infantile neuronal ceroid lipofuscinosis.</a> July 8  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9820841/'>Interaction of human papillomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex.</a> November 20  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/11296479/'>Two Drosophila melanogaster homologues of the human TAFII30 have different functions.</a> April 12  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12762840/'>Novel complex integrating mitochondria and the microtubular cytoskeleton with chromosome remodeling and tumor suppressor RASSF1 deduced by in silico homology analysis, interaction cloning in yeast, and colocalization in cultured cells.</a> May 24  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14732493/'>Downregulation of genes involved in DNA repair and differential expression of transcription regulators and phosphatases precede IgM-induced apoptosis in the Burkitt's lymphoma cell line BL60-2.</a> January 21  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/17599049/'>Estrogen-induced and TAFII30-mediated gene repression by direct recruitment of the estrogen receptor and co-repressors to the core promoter and its reversal by tamoxifen.</a> June 30  2007<br></body></html>
